Jim Simons Biocept Inc Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.24 - $0.62 $7,545 - $19,493	31,441 Added 19.37%	193,741 $66,000
Q4 2022 Feb 13, 2023	SELL	$0.47 - $0.89 $2,867 - $5,429	-6,100 Reduced 3.62%	162,300 $86,000
Q3 2022 Nov 14, 2022	SELL	$0.75 - $1.2 $5,325 - $8,520	-7,100 Reduced 4.05%	168,400 $155,000
Q2 2022 Aug 12, 2022	BUY	$0.88 - $2.27 $52,008 - $134,157	59,100 Added 50.77%	175,500 $165,000
Q1 2022 May 13, 2022	BUY	$1.83 - $3.97 $45,384 - $98,456	24,800 Added 27.07%	116,400 $270,000
Q4 2021 Feb 11, 2022	BUY	$3.43 - $4.22 $139,944 - $172,176	40,800 Added 80.31%	91,600 $332,000
Q3 2021 Nov 12, 2021	BUY	$3.39 - $4.34 $172,212 - $220,472	50,800 New	50,800 $204,000
Q4 2020 Feb 10, 2021	SELL	$4.31 - $6.16 $46,849 - $66,959	-10,870 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.61 - $11.4 $39,240 - $123,918	10,870 New	10,870 $48,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.